Immunotherapy decreases skin sensitivity to cat extract.

Area of Science:

• Allergy and Immunology
• Respiratory Medicine
• Immunotherapy

Background:

• Cat allergy is a common condition causing asthma symptoms.
• Standard treatments focus on symptom management, not addressing the underlying hypersensitivity.
• Immunotherapy offers a potential disease-modifying approach.

Purpose of the Study:

• To evaluate the efficacy of cat allergen immunotherapy in reducing allergic sensitivity in patients with cat asthma.
• To compare the effects of active immunotherapy versus placebo.

Main Methods:

• A double-blind, placebo-controlled study involving 22 cat-allergic asthma patients.
• Patients received either cat-hair and dander extract immunotherapy or placebo.
• Skin tests (intradermal and prick) and bronchial challenge tests (methacholine) were performed before and after one year of treatment.

Main Results:

• Immunotherapy significantly decreased skin sensitivity to cat allergens as measured by both intradermal and prick tests.
• Bronchial sensitivity, indicated by the dose of cat extract causing a 20% fall in FEV1, was significantly reduced in the treated group.
• Treated patients showed significant increases in IgG and IgE antibodies against cat allergens.

Conclusions:

• One year of cat allergen immunotherapy effectively reduces both skin and bronchial hypersensitivity in patients with cat asthma.
• The observed immunological changes, including increased antibody levels, support the mechanism of action for immunotherapy.
• Cat allergen immunotherapy represents a viable treatment option for managing cat-induced asthma by targeting allergic sensitization.